These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Insulin resistance and exendin-4 treatment for multiple system atrophy. Bassil F; Canron MH; Vital A; Bezard E; Li Y; Greig NH; Gulyani S; Kapogiannis D; Fernagut PO; Meissner WG Brain; 2017 May; 140(5):1420-1436. PubMed ID: 28334990 [TBL] [Abstract][Full Text] [Related]
8. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733 [TBL] [Abstract][Full Text] [Related]
9. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103 [TBL] [Abstract][Full Text] [Related]
10. Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications. Schafferer S; Khurana R; Refolo V; Venezia S; Sturm E; Piatti P; Hechenberger C; Hackl H; Kessler R; Willi M; Gstir R; Krogsdam A; Lusser A; Poewe W; Wenning GK; Hüttenhofer A; Stefanova N PLoS One; 2016; 11(3):e0150705. PubMed ID: 26962858 [TBL] [Abstract][Full Text] [Related]
11. Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. Redmond DE; Elsworth JD; Roth RH; Leranth C; Collier TJ; Blanchard B; Bjugstad KB; Samulski RJ; Aebischer P; Sladek JR J Comp Neurol; 2009 Jul; 515(1):31-40. PubMed ID: 19399891 [TBL] [Abstract][Full Text] [Related]
12. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Stefanova N; Reindl M; Neumann M; Kahle PJ; Poewe W; Wenning GK Mov Disord; 2007 Nov; 22(15):2196-203. PubMed ID: 17853477 [TBL] [Abstract][Full Text] [Related]
13. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617 [TBL] [Abstract][Full Text] [Related]
14. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease. Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532 [TBL] [Abstract][Full Text] [Related]
15. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates. Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725 [TBL] [Abstract][Full Text] [Related]
16. High dose levodopa therapy is not toxic in multiple system atrophy: experimental evidence. Stefanova N; Köllensperger M; Hainzer M; Cenci A; Poewe W; Wenning GK Mov Disord; 2007 May; 22(7):969-73. PubMed ID: 17427936 [TBL] [Abstract][Full Text] [Related]
17. ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy. Heras-Garvin A; Refolo V; Schmidt C; Malfertheiner K; Wenning GK; Bradbury M; Stamler D; Stefanova N Mov Disord; 2021 Nov; 36(11):2605-2614. PubMed ID: 34236731 [TBL] [Abstract][Full Text] [Related]
19. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Stemberger S; Poewe W; Wenning GK; Stefanova N Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840 [TBL] [Abstract][Full Text] [Related]
20. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Ubhi K; Rockenstein E; Mante M; Patrick C; Adame A; Thukral M; Shults C; Masliah E Neuroreport; 2008 Aug; 19(13):1271-6. PubMed ID: 18695506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]